Evaluation of the effects of fasting diet in patients with rheumatoid arthritis
Not Applicable
Recruiting
- Conditions
- Rheumatoid Arthritis.Rheumatoid arthritis with rheumatoid factor
- Registration Number
- IRCT20230217057441N1
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 44
Inclusion Criteria
Women
Body mass index 25-35 kg/m2
Age range between 50 and 70 years
Menopause
Diagnosed with rheumatoid arthritis by a rheumatologist for more than 6 months
Moderate to low rheumatoid arthritis disease activity (i.e. disease activity score <5.1)
Following a stable drug regimen for 3 months before the intervention
Not receiving non-steroidal anti-inflammatory drugs (NSAIDs)
Willingness to cooperate
Exclusion Criteria
Consumption of alcohol
Suffering from other autoimmune diseases, kidney diseases, pancreatitis, gallstones, cancer
Pregnancy and breastfeeding
Following a special diet in the last three months
Changing the medication regimen from 3 months
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method In this study, HAQ score is considered as the primary outcome. Timepoint: Investigating the effects of clinical symptoms, inflammation and oxidative stress at the beginning of the study (before the start of the intervention) and 8 weeks after the start of the intermittent fasting diet in postmenopausal, overweight and obese women with rheumatoid arthritis. Method of measurement: Questionnaire for health assessment-disability index: In order to evaluate the performance of patients, it will be completed by the project manager at the beginning and end of the study, and by asking the patients.
- Secondary Outcome Measures
Name Time Method